Grupo farmacéutico · Estados Unidos
Pfizer
Un grupo de 190 empresas con 3955 medicamentos en 12 países.
Estructura del grupo
190 empresas en 32 países
Cargando…
Grupo farmacéutico · Estados Unidos
Un grupo de 190 empresas con 3955 medicamentos en 12 países.
190 empresas en 32 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 3955
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| A-HYDROCORT100mg base/vial | 1gm base/vial | 250mg base/vial | 500mg base/vial · Injectable | Hydrocortisone | Estados Unidos | No comercializado | 1978 |
| A-METHAPRED125mg base/vial | 1gm base/vial | 40mg base/vial | 500mg base/vial · Injectable | Methylprednisolone | Estados Unidos | No comercializado | 1978 |
| ABRILADA10mg/0.2ml | 20mg/0.4ml | 40mg/0.8ml · Injectable | Adalimumab | Estados Unidos | Comercializado | 2019 |
| Abrilada40mg/0.8ml · Injection | Adalimumab | Estados Unidos | Comercializado | 2019 |
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Canadá | Comercializado | 2022 |
| Abrilada10mg/0.2ml · Injection | Adalimumab | Estados Unidos | No comercializado | 2019 |
| ABRILADA40 mg / 0.8 ml · Kit, Solution | Adalimumab | Canadá | Autorizado | |
| ABRILADA10 mg / 0.2 ml · Solution | Adalimumab | Canadá | Autorizado | |
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Canadá | Comercializado | 2022 |
| ABRILADA20 mg / 0.4 ml · Solution | Adalimumab | Canadá | Comercializado | 2023 |
| ABRILADA SOLUTION FOR INJECTION IN SINGLE-DOSE PREFILLED PEN 40 MG/0.8 ML40mg/0.8ml · Injection, solution | Adalimumab | Singapur | Autorizado | 2022 |
| ABRYSVO | Vacina vírus sincicial respiratório a e b | Brasil | Autorizado | 2024 |
| Abrysvo | Respiratory syncytial virus vaccines | UE (EMA) | Autorizado | 2023 |
| Abrysvo120ug · Injection | Respiratory syncytial virus vaccines | Estados Unidos | Comercializado | 2023 |
| ABRYSVO60 mcg / 0.5 ml + 60 mcg / 0.5 ml · Kit, Powder For Solution | Rsv subgroup a stabilized prefusion f protein, Rsv subgroup b stabilized prefusion f protein | Canadá | Comercializado | 2024 |
| Abrysvo poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Recombinant respiratoir syncytieel virus subgroep a prefusie f antigeen, Recombinant respiratoir syncytieel virus subgroep b prefusie f antigeen | Países Bajos | Autorizado | 2023 |
| Abrysvo poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Recombinant respiratoir syncytieel virus subgroep a prefusie f antigeen, Recombinant respiratoir syncytieel virus subgroep b prefusie f antigeen | Países Bajos | Autorizado | 2023 |
| ABRYSVO POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE0,06 mg + 0,06 mg · Polvo y disolvente para solución inyectable | Virus sincitial respiratorio, subgroupo a, subunidad f proteina estabilizada en prefusion, Virus sincitial respiratorio, subgroupo b, subunidad f proteina estabilizada en prefusion | España | Comercializado | 2023 |
| ABRYSVO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION0.06 mg/vial + 0.06 mg/vial · Injection, powder, for solution | Rsv subgroup a stabilized prefusion f protein, Rsv subgroup b stabilized prefusion f protein | Singapur | Autorizado | 2024 |
| ACCUPRIL10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE * · Tablet | Quinapril | Estados Unidos | No comercializado | 1991 |
| ACCURETIC12.5MG; 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 12.5MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG; 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness · Tablet | Hydrochlorothiazide, Quinapril | Estados Unidos | No comercializado | 1999 |
| Aciclovir Hospira 25 mg/ml, concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie | Aciclovir | Países Bajos | Autorizado | 1999 |
| ADCETRIS50 mg / vial · Powder For Solution | Brentuximab vedotin | Canadá | Comercializado | 2013 |
| ADRIAMYCIN PFS2 mg / ml · Solution | Doxorubicin | Canadá | No comercializado | 1995 |
| ADRIAMYCIN PFS200mg/100ml | 2mg/ml · Injectable | Doxorubicin | Estados Unidos | No comercializado | 1991 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 1083 | 278 | 805 | EmpresasTodos los medicamentos |
| Estados Unidos | 648 | 643 | 5 | EmpresasTodos los medicamentos |
| Brasil | 516 | 85 | 431 | EmpresasTodos los medicamentos |
| Arabia Saudí | 444 | 444 | 0 | EmpresasTodos los medicamentos |
| España | 370 | 311 | 59 | EmpresasTodos los medicamentos |
| Rumanía | 241 | 0 | 241 | EmpresasTodos los medicamentos |
| Países Bajos | 221 | 221 | 0 | EmpresasTodos los medicamentos |
| Singapur | 165 | 165 | 0 | EmpresasTodos los medicamentos |
| Serbia | 117 | 111 | 6 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 96 | 56 | 40 | EmpresasTodos los medicamentos |
| Croacia | 49 | 49 | 0 | EmpresasTodos los medicamentos |
| Colombia | 5 | 0 | 5 | EmpresasTodos los medicamentos |
También en los registros de Alemania, Australia, Francia, Italia, Malasia, Reino Unido, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licencia: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licencia: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos, dataset vwwf-4ftk, rowsUpdatedAt 1792152641, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Bundesinstitut für Arzneimittel und Medizinprodukte, pediatric list, acquired 2026-10-29T14:36:58.614273+00:00
Licencia: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte, urgent list, acquired 2026-10-29T14:36:58.856157+00:00
Licencia: commercial redistribution permission not established
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), published shortage reports CSV, retrieved 2026-10-28.
Licencia: commercial redistribution permission not established
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licencia: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA factual register
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licencia: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
GLEIF; exact source URL and retrieval date; no endorsement.
Licencia: CC0
Companies Registry, Government of the Hong Kong Special Administrative Region, via DATA.GOV.HK; exact dataset/resource URL, original CSV URL, retrieval date, and notice of selection/normalization by Prognia; no endorsement.
Licencia: DATA.GOV.HK Terms of Use
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licencia: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Saudi Food and Drug Authority (SFDA), local human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Pfizer en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.